BRIDGEBIO PHARMA INC (BBIO)

13F ownership of BRIDGEBIO PHARMA INC among the superinvestors tracked on fructus.finance, based on their latest quarterly SEC filings.

Price history

Loading...
Tracked holders
6
Combined value
$1.2B
New buyers this quarter
4

Superinvestors holding BBIO

A
Andreas Halvorsen
Viking Global Investors LP 路 Q2 2026
$741M
2.11% of portfolio (-16%)
Trimmed
K
Ken Griffin
Citadel Advisors LLC 路 Q2 2026
$280M
0.03% of portfolio
New buy
S
Steven Cohen
Point72 Asset Management, L.P. 路 Q2 2026
$114M
0.13% of portfolio
New buy
J
Jim Simons
Renaissance Technologies LLC 路 Q2 2026
$64M
0.09% of portfolio
New buy
R
Ray Dalio
Bridgewater Associates, LP 路 Q2 2026
$33M
0.14% of portfolio
New buy
P
Polen Capital
Polen Capital Management LLC 路 Q2 2026
$298K
0.00% of portfolio (-91.3%)
Trimmed

Based on 13F filings submitted to the SEC, published with roughly 45 days of lag. Only long equity positions are captured. See our guide on how to read a 13F filing for more context, or browse the full superinvestor consensus.